Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Methacholine for Inhalation
NCT06730620Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jan 2024
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methacholine in asthma (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Peak Concentration at 8 hours, Area under the blood concentration time curve from 0 to last time point at 8 hours and 1 more. Started Jan 2024; status: completed.
02
Drugs
methacholine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06730620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06730620.